For example, Rac1b, a constitutively active isoform of Rac1, are overexpressed in breast carcinomas, while Rac1 and Cdc42 are associated with growth-factor-mediated proliferation, invasion, and therapeutic resistance [6,7]. Here, RAC1 is linked to breast carcinoma.